Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.


OBJECTIVE Doxorubicin is a potent anti-cancer agent with efficacy against a broad range of tumors, including endometrial cancer. Doxorubicin produces reactive oxygen species (ROS) resulting in cytotoxicity. Tetrathiomolybdate (TM), a copper-chelating agent, is known to target a cellular antioxidant enzyme copper/zinc-superoxide dismutase. This study tests… (More)
DOI: 10.1016/j.ygyno.2011.03.035


  • Presentations referencing similar topics